Results 11 to 20 of about 368,846 (181)
Rotavirus vaccine effectiveness and impact in Uzbekistan, the first country to introduce in central Asia
Human Vaccines & Immunotherapeutics, 2021 Uzbekistan, the most populous country in central Asia, was the first in the region to introduce rotavirus vaccine into its national immunization program.Umid Eraliev, Renat Latipov, Dilorom Tursunova, Annemarie Wasley, Danni Daniels, Umed Ismoilov, Manzura Akramova, Mehri Sultanova, Dilbar Yuldashova, Bahodir Barakaev, Vazira Mutalova, Laziz Tuychiev, Erkin Musabaev, Said Sharapov, Boris Pleshkov, Dovile Videbaek, Shahin Huseynov, Kamola Safaeva, Slavica Mijatovic-Rustempasic, Michael D. Bowen, Umesh D. Parashar, Margaret M. Cortese +21 moredoaj +1 more sourceIncidence and clinical characteristics of group A rotavirus infections among children admitted to hospital in Kilifi, Kenya [PDF]
, 2008 Background
Rotavirus, predominantly of group A, is a major cause of severe diarrhoea worldwide, with
the greatest burden falling on young children living in less-developed countries.Peenze, Ina, Maghenda, J. Kamino, Maitland, Kathryn, J Anthony G Scott, J Kamino Maghenda, Dewar, J, Kathryn Maitland, Scott, John, Allan Pamba, Thomas N Williams, Williams, TN, Maitland, K, Bauni, Evasius, Dewar, John, Scott, J. Anthony G., Hellen Gatakaa, Pamba, A, Evasius Bauni, Williams, Thomas N., Maghenda, J Kamino, John Abwao, Peenze, I, John Dewar, Nokes, D. James, Nokes, DJ, Scott, JA, Bauni, E, Scott, J Anthony G, Williams, Thomas N, D James Nokes, Maghenda, JK, Pamba, Allan, Williams, Thomas, Ina Peenze, Gatakaa, Hellen, Nokes, D James, Abwao, J, Gatakaa, H, Abwao, John, Nokes, TN +39 morecore +1 more sourceHousehold Transmission of Rotavirus in a Community with Rotavirus Vaccination in Quininde, Ecuador [PDF]
, 2013 Background: We studied the transmission of rotavirus infection in households in peri-urban Ecuador in the vaccination era.
Methods: Stool samples were collected from household contacts of child rotavirus cases, diarrhea controls and healthy controls ...Martha Chico, Daniel Payne, Payne, Daniel, Ben Lopman (41533), Michael D. Bowen, Vicuña, Y, Esona, Matthew D., Chico, Martha, Fabian Salazar, Lopman, B, Sandoval, C, Bowen, MD, Nely Broncano, Nicole Gregoricus, Vicuña Yosselin, Vaca, Martiza, Ben Lopman, Chico, M, Martha Chico (270482), Yosselin Vicuña (432014), Vaca, M, Yosselin Vicuña, Broncano Nely, Umesh Parashar, Payne Daniel, Matthew D Esona, Gregoricus, N, Cooper, PJ, Cooper, Philip, Vicuña, Yosselin, Parashar Umesh, Broncano, Nely, Broncano, N, Fabian Salazar (432015), Carlos Sandoval (314735), Chico Martha, Nely Broncano (218294), Esona, MD, Michael D Bowen, Nicole Gregoricus (161222), Salazar, F, Gregoricus Nicole, Parashar, U, Matthew D. Esona, Daniel Payne (432018), Michael D. Bowen (432017), Salazar Fabian, Martiza Vaca (432019), Parashar, Umesh, Payne, D, Philip J. Cooper, Carlos Sandoval, Matthew D. Esona (432016), Umesh Parashar (432020), Gregoricus, Nicole, Cooper Philip J., Salazar, Fabian, Bowen, Michael D., Philip J. Cooper (218309), Esona Matthew D., Bowen Michael D., Sandoval, Carlos, Lopman Ben, Lopman, Ben, Sandoval Carlos, Vaca Martiza, Philip J Cooper, Martiza Vaca +67 morecore +2 more sourcesRotavirus genetic diversity, disease association, and temporal change in hospitalized rural Kenyan children [PDF]
, 2010 Background. The effectiveness of rotavirus vaccines will be dependent on the immunity conferred against prevalent and emergent variants causing severe diarrheal disease.Peenze, Ina, Williams, Thomas N., Peenze, I, Netshifhefhe, Lufuno, Seheri, Mapaseka, De Beer, MC, Nokes, D. James, Nokes, DJ, Seheri, M, Steele, D, De Beer, Mariet C., Williams, TN, Netshifhefhe, L, Williams, Thomas, Page, N, De Beer, De, Abwao, J, Abwao, John, Page, Nicola, Steele, Duncan +19 morecore +1 more sourceRotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand
Human Vaccines & Immunotherapeutics, 2017 Background: Maternal antibodies, acquired passively via placenta and/or breast milk, may contribute to the reduced efficacy of oral rotavirus vaccines observed in children in developing countries.Mee-Yew Chen, Carl D. Kirkwood, Julie Bines, Daniel Cowley, Daniel Pavlic, Katherine J. Lee, Francesca Orsini, Emma Watts, Graeme Barnes, Margaret Danchin +9 moredoaj +1 more sourceMaternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (RotarixTM) Immunogenicity among Infants in Zambia
Vaccines, 2023 Live-attenuated, oral rotavirus vaccines have significantly reduced rotavirus-associated diarrhoea morbidity and infant mortality. However, vaccine immunogenicity is diminished in low-income countries.Adriace Chauwa, Samuel Bosomprah, Natasha Makabilo Laban, Bernard Phiri, Mwelwa Chibuye, Obvious Nchimunya Chilyabanyama, Sody Munsaka, Michelo Simuyandi, Innocent Mwape, Cynthia Mubanga, Masuzyo Chirwa Chobe, Caroline Chisenga, Roma Chilengi +12 moredoaj +1 more sourceRotavirus vaccine and health-care utilization for rotavirus gastroenteritis in Tsu City, Japan
Western Pacific Surveillance and Response, 2016 Background: Rotavirus vaccines were introduced in Japan in November 2011. We evaluated the subsequent reduction of the health-care burden of rotavirus gastroenteritis.Kazutoyo Asada, Hajime Kamiya, Shigeru Suga, Mizuho Nagao, Ryoji Ichimi, Takao Fujisawa, Masakazu Umemoto, Takaaki Tanaka, Hiroaki Ito, Shigeki Tanaka, Masaru Ido, Koki Taniguchi, Toshiaki Ihara, Takashi Nakano +13 moredoaj +1 more sourceBivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
iScience, 2022 Summary: Non-replicating rotavirus vaccines are an alternative strategy to improve the efficacy and safety of rotavirus vaccines. The spike protein VP4, which could be enzymatically cleaved into VP8∗ and VP5∗, is an ideal target for the development of ...Guoxing Luo, Yuanjun Zeng, Han Yang, Yijian Li, Lianwei Yang, Cao Li, Feibo Song, Shiyin Zhang, Tingdong Li, Shengxiang Ge, Jun Zhang, Ningshao Xia +11 moredoaj +1 more source